Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Afify, Said M  [Clear All Filters]
Journal Article
Chen L, Liu Y, Xu Y, Afify SM, Gao A, Du J, Liu B, Fu X, Liu Y, Yan T, et al. Up-regulation of Dsg2 confered stem cells with malignancy through wnt/β-catenin signaling pathway. Exp Cell Res. 2022:113416.
Osman A, Oze M, Afify SM, Hassan G, El-Ghlban S, Nawara HM, Fu X, Zahra MHussein, Seno A, Winer I, et al. Tumor-associated macrophages derived from cancer stem cells. Acta Histochem. 2020;122(8):151628.
Hassan G, Afify SM, Du J, Nawara HM, Sheta M, Monzur S, Zahra MH, Quora HAAbu, Mansour H, El-Ghlban S, et al. MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway. Biochem Biophys Res Commun. 2021;583:49-55.
Hassan G, Afify SM, Zahra MH, Nawara HM, Kumon K, Iwasaki Y, Salomon DS, Seno A, Seno M. GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation. Cytotechnology. 2023;75(3):243-253.
Afify SM, Hassan G, Ishii H, Monzur S, Nawara HM, Osman A, Quora HAAbu, Sheta M, Zahra MH, Seno A, et al. Functional and Molecular Characters of Cancer Stem Cells Through Development to Establishment. Adv Exp Med Biol. 2022;1393:83-101.
Minematsu H, Afify SM, Sugihara Y, Hassan G, Zahra MH, Seno A, Adachi M, Seno M. Cancer stem cells induced by chronic stimulation with prostaglandin E2 exhibited constitutively activated PI3K axis. Sci Rep. 2022;12(1):15628.
Zahra MH, Nawara HM, Hassan G, Afify SM, Seno A, Seno M. Cancer Stem Cells Contribute to Drug Resistance in Multiple Different Ways. Adv Exp Med Biol. 2022;1393:125-139.
Afify SM, Hassan G, Yan T, Seno A, Seno M. Cancer Stem Cell Initiation by Tumor-Derived Extracellular Vesicles. Methods Mol Biol. 2021.
Hassan G, Du J, Afify SM, Seno A, Seno M. Cancer stem cell generation by silenced MAPK enhancing PI3K/AKT signaling. Med Hypotheses. 2020;141:109742.